Previous Page  31 / 44 Next Page
Information
Show Menu
Previous Page 31 / 44 Next Page
Page Background

Notes:

Page 92

Chromatography 2016

September 21-23, 2016

Volume 7, Issue 5(Suppl)

J Chromatogr Sep Tech 2016

ISSN: 2157-7064 JCGST, an open access journal

conferenceseries

.com

September 21-23, 2016 Amsterdam, Netherlands

World Congress on

Chromatography

Formulation of telmisartan tablet, evaluation and determination by HPLC

Kahtan J Hasson

Al-Rasheed University College, Iraq

T

elmisartan is an angiotensin ІІ type and is used as antihypertensive drug. It poses poor solubility which leads to low

bioavailability in blood stream so that; this problem guides many scientists to work in improvement of telmisartan

dissolution of its solid dosage forms. The present work shows the formulations of telmisartan as tablet with high enhancement

degree in their dissolutions and stability in addition to the improvement in the physical characters of the tablet dosage forms.The

formulations of telmisartan were prepared in consideration of manufacturing conditions rather than laboratory productions

as it is prescribed over many previous academic papers. The manufacturing procedure of the tablet according to this new

formulation is simple and readily applicable in pharmaceutical industries. The method depend on turning the telmisartan to

amorphous crystals by mixing with solubilizing polymer and mixed with prepared DC excipients to be compressed as tablets.

The DC excipients were modified during the preparation to act as alkalizing agent which in turn enhanced the dissolution

rate of the tablets. The physical properties of the powder of formulations were evaluated and it gave an excellent degree of

flowability and compressibility while, the compressed tablets showed fast disintegration time and very low friability percent. In

addition the dissolution profiles of the produced tablet were more than 85%. For a comprehensive evaluation of this formulation

procedure of tablets, a stability indicating method of analysis was developed by using reversed phase HPLC technique to

follow the expected changing that might occur on storage of the product (tablets) at accelerated conditions of storage. The

HPLC method was able to detect the degradation products of telmisartan in deliberately degraded sample and the produced

telmisartan tablets which were stored at accelerated conditions showed good stability.

Biography

Kahtan J Hasoon has obtained his BSc in Pharmaceutical Sciences from College of Pharmacy, Baghdad University. He obtained his MSc in Pharmaceutical

Analysis from Herriot-Watt University, UK. He has been a Member of Academic Staff of Al-Mustansiriya University. Now he is a Lecturer in the Al-Rasheed University

College, and as a Technical Consultant in SAFA Pharmaceutical Industries Co., Al-Safa Group.

kjhassoun@yahoo.com

Kahtan J Hasson, J Chromatogr Sep Tech 2016, 7:5(Suppl)

http://dx.doi.org/10.4172/2157-7064.C1.017